Hematology/Oncology Education and CME

Select a Specialty

ATC
CMEABIM MOC

Ace the Case: A 33-Year-Old Woman with a Mass in Her Right Breast

There is no commercial support for this activity.

Expiration Date: 4/15/2019
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will utilize a case study to discuss the diagnosis and management of a breast mass in a 33-year-old woman….

go to activity»
Lung Cancer Central: Exploring Today's Patient Outlook and Treatment Innovations

Lung Cancer Central is a new source for treatment breakthroughs, clinical trial news and expert analysis….

go to activity»
HEA055
CMEABIM MOC

Ace the Case: A 48-Year-Old Woman Confused About a Diagnosis of Leukemia

There is no commercial support for this activity.

Expiration Date: 3/14/2019
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This “Ace the Case” activity will utilize a case study to discuss the assessment and management of a 48-year-old woman with a myeloproliferative disorder. Accurately…

go to activity»
Rheumatic Immune-related Adverse Events: Multidisciplinary Perspectives on Recognition and Management
CME

Rheumatic Immune-related Adverse Events: Multidisciplinary Perspectives on Recognition and Management

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 2/20/2019
Credit Type(s): CME | Credit: 1.5

The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new therapies are associated with a spectrum of…

go to activity»
M509

Anil K. Rustgi, MD, serves as the division chief of gastroenterology at the University of Pennsylvania's Perelman School of Medicine in Philadelphia. Rustgi and his…

go to activity»
J632
CME

Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers

This educational activity is supported by an independent medical educational grant from Merck & Co., Inc.

Expiration Date: 2/5/2019
Credit Type(s): CME | Credit: 0.75

The genomes of cancers deficient in mismatch repair (MMR) contain extremely high numbers of somatic mutations. Analysis of recent clinical studies have demonstrated that…

go to activity»
Virtual NSCLC: Updates in Combining Immunotherapy with Other Treatment Modalities
CME

Virtual NSCLC: Updates in Combining Immunotherapy with Other Treatment Modalities

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 4/9/2019
Credit Type(s): CME | Credit: 0.75

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be about 234,030 new cases of lung cancer and about…

go to activity»
Renal Cell Carcinoma Central: Focus on Facts, Fundamentals and the Future

Renal Cell Carcinoma Central is here, your hub for treatment breakthroughs, clinical trial news and expert analysis….

go to activity»
Immune Checkpoint Inhibitors for Genitourinary Cancers Practice Essential
CMECNECPE

Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 2/23/2019
Credit Type(s): CME / CNE / CPE | Credit: 0.5

For many years, the mainstay of initial treatment for metastatic bladder cancer has been chemotherapy. However, immunotherapy with PD-1/PD-L1 checkpoint inhibitors is…

go to activity»
Improving Colorectal Cancer Prevention: Latest Advances to Improve Adenoma Detection Rates
CME

Improving Colorectal Cancer Prevention: Latest Advances to Improve Adenoma Detection Rates

This activity is supported by an educational grant from Aries Pharmaceuticals Inc.

Expiration Date: 2/1/2019
Credit Type(s): CME | Credit: 1.25

Colorectal cancer (CRC) is the third most common type of cancer worldwide and second deadliest form of cancer in the United States. Current estimates suggest that up to…

go to activity»
brown pigmented legion
CMEABIM MOC

Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing Over the Past 3 Months

There is no commercial support for this activity.

Expiration Date: 2/14/2019
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who has a brown pigmented lesion that has been changing…

go to activity»
EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care
CME

EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Expiration Date: 1/16/2019
Credit Type(s): CME | Credit: 0.5

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of all cancer-related deaths. In 2018, it is…

go to activity»